{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:57:29Z","timestamp":1780117049566,"version":"3.54.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T00:00:00Z","timestamp":1391040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087660","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T22:28:00Z","timestamp":1391120880000},"page":"e87660","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Activation of the PI3K\/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat"],"prefix":"10.1371","volume":"9","author":[{"given":"Xiang Shan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Furubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuni","family":"Nakanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,30]]},"reference":[{"key":"ref1","first-page":"223","article-title":"Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli\u2019s disease with congenital hepatic fibrosis and biliary atresia","volume":"25","author":"Y Nakanuma","year":"2010","journal-title":"Histol Histopathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"PC Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"ref3","first-page":"1605","article-title":"Polycystic kidney rat is a novel animal model of Caroli\u2019s disease associated with congenital hepatic fibrosis. Am J Pathol","volume":"158","author":"T Sanzen","year":"2001"},{"key":"ref4","article-title":"Caroli\u2019s disease: current knowledge of its biliary pathogenesis obtained from an orthologous rat model","author":"Y Sato","year":"2012","journal-title":"Int J Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/138920310791824093","article-title":"The complexes of mammalian target of rapamycin","volume":"11","author":"H Zhou","year":"2010","journal-title":"Curr Protein Pept Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-08-3014","article-title":"TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2","volume":"69","author":"J Copp","year":"2009","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/hep.23511","article-title":"Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice","volume":"51","author":"C Spirli","year":"2010","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"JM Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","author":"I Zafar","year":"2010","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/ndt\/gfl246","article-title":"Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?","volume":"21","author":"G Walz","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"JM Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"AL Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"G Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ndt\/gfq384","article-title":"Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats","volume":"26","author":"C Renken","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD)","volume":"24","author":"DC Fischer","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1158\/0008-5472.CAN-10-1814","article-title":"Activity of the novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia","volume":"70","author":"F Chiarini","year":"2010","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1158\/1535-7163.MCT-09-0160","article-title":"NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas","volume":"8","author":"TJ Liu","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00019606-199804000-00001","article-title":"Pathogenesis of autosomal dominant polycystic kidney disease: role of apoptosis","volume":"7","author":"XJ Zhou","year":"1998","journal-title":"Diagn Mol Pathol"},{"key":"ref19","first-page":"1153","article-title":"Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD)","volume":"13","author":"J Lanoix","year":"1996","journal-title":"Oncogene"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM199507063330104","article-title":"Apoptosis and loss of renal tissue in polycystic kidney diseases","volume":"333","author":"D Woo","year":"1995","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yexcr.2010.09.012","article-title":"Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys","volume":"317","author":"B Hu","year":"2011","journal-title":"Exp Cell Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"F1235","DOI":"10.1152\/ajprenal.00348.2010","article-title":"Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) and autophagy in polycystic kidney disease (PKD)","volume":"300","author":"F Belibi","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9440(10)62231-6","article-title":"Activation of the MEK5\/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli\u2019s disease","volume":"166","author":"Y Sato","year":"2005","journal-title":"Am J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.ajpath.2011.08.028","article-title":"Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) rat","volume":"179","author":"XS Ren","year":"2011","journal-title":"Am J Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/hep.25600","article-title":"V-AKT murine thymoma viral oncogene homolog\/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis","volume":"55","author":"M Evert","year":"2012","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2215\/CJN.05611207","article-title":"Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease","volume":"3","author":"CL Edelstein","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","first-page":"1273","article-title":"Growth inhibition by NVP-BEZ235, a dual PI3K\/mTOR inhibitor, in hepatocellular carcinoma cell lines","volume":"26","author":"M Masuda","year":"2011","journal-title":"Oncol Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1158\/1078-0432.CCR-10-2289","article-title":"Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma","volume":"17","author":"C Santiskulvong","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2011.12.024","article-title":"Inhibition of PI3K\/mTOR leads to adaptive resistance in matrix-attached cancer cells","volume":"21","author":"T Muranen","year":"2012","journal-title":"Cancer Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jmcb\/mjq038","article-title":"mTORC1 signaling: what we still don\u2019t know","volume":"3","author":"X Wang","year":"2011","journal-title":"J Mol Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4161\/auto.6.4.11671","article-title":"Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells","volume":"6","author":"P Sini","year":"2010","journal-title":"Autophagy"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4161\/cc.8.7.8044","article-title":"Targeting mTOR with rapamycin: one dose does not fit all","volume":"8","author":"DA Foster","year":"2009","journal-title":"Cell Cycle"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e27509","DOI":"10.1371\/journal.pone.0027509","article-title":"S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer","volume":"6","author":"R Nawroth","year":"2011","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2353\/ajpath.2006.051136","article-title":"Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib","volume":"169","author":"Y Sato","year":"2006","journal-title":"Am J Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:07:27Z","timestamp":1540346847000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087660"}},"subtitle":[],"editor":[{"given":"Jin Q.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087660","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,30]]}}}